Fish Vaccine Market

Due to excessive stocking densities, low oxygen levels, poor water quality, and high pathogen loads, the fish culture environment, whether it be in tanks, cages, ponds, seawater, or freshwater, can stress the fish. As a result, farmed fish are more susceptible to infectious diseases than farmed animals. These illnesses could have bacterial, viral, fungal, or parasitic causes. The most effective defense against viral and bacterial illnesses is vaccination. In the fight against infectious illnesses, vaccine has been a crucial instrument for the livestock, pig, poultry, and salmon industries.

Market Dynamics

Market players are focused on strategies such as acquisitions, which is expected to drive the growth of the global fish vaccine market over the forecast period. For instance, in December 2018, Phibro Animal Health Corp., a manufacturer of vaccines and medicated feed additives, acquired aquaculture vaccine maker KoVax Ltd. The acquisition strengthened the position of Phibro Animal Health Corp. in fish vaccine innovation and expanded its portfolio of aquaculture products.

Increasing research and development activities related to fish vaccine is expected to fuel the growth of the global fish vaccine market. For instance, in 2018, Lumen Bioscience, a biotechnology company, initiated the next phase of a project to develop an oral vaccine, in order to protect farmed salmonid fish such as trout and salmon from infectious hematopoietic necrosis virus (IHNV). In the same year, the company received a grant from the U.S. Department of Agriculture (USDA).

Market players are engaged in inorganic activities such as partnerships, which is expected to augment the global fish vaccine market growth over the forecast period. For instance, in 2017, Barramundi Group, a marine health company, entered into partnership with WWF-Singapore (World Wide Fund) to improve its Singapore farm sites in view of adding the Aquaculture Stewardship Council (ASC) standard to its list of accolades. Under this agreement, WWF-Singapore will provide advice and guidance in terms of the implementation of the aquaculture improvement work plan, as well as mark out milestones to address gaps between current practices and the ASC standard.

Key features of the study:

• This report provides an in-depth analysis of the global fish vaccine market, market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global fish vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include HIPRA, VETERQUIMICA SA, Ictyogroup, Kyoto Biken Laboratories, Inc., Vaxxinova International BV, Barramundi Group, Merck & Co., Inc., Zoetis Inc., KBNP, INC., Aqua Vet S.A., and NISSEIKEN CO., LTD
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global fish vaccine market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global fish vaccine market

Detailed Segmentation:

• Global Fish Vaccine Market, By Vaccine Type:
  • Killed Vaccine
  • Inactivated Vaccine
  • Attenuated Vaccine
  • Toxoid Vaccine
  • Subunit Vaccine
  • Conjugate Vaccine
  • Recombinant Vector Vaccines
• Global Fish Vaccine Market, By Indication:
  • Furunculosis
  • Vibriosis
  • Yersiniosis
  • Enteric septicaemia
  • Others
• Global Fish Vaccine Market, By Route of Administration:
  • Injection
  • Immersion
  • Spray
  • Oral
• Global Fish Vaccine Market , By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific

• • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • HIPRA*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • VETERQUIMICA SA
  • Ictyogroup
  • Kyoto Biken Laboratories, Inc.
  • Vaxxinova International BV
  • Barramundi Group
  • Merck & Co., Inc.
  • Zoetis Inc.
  • KBNP, INC.
  • Aqua Vet S.A.
  • NISSEIKEN CO., LTD

 “*” marked represents similar segmentation in other categories in the respective section.